阿尔提免疫公司
US ˙ NasdaqGM ˙ US02155H2004

介绍

本页面提供了有关 John Pappajohn 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示John Pappajohn已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:US87946W2026 / TELEMYND INC Director, 10% Owner 1,000,000
US:MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Director, 10% Owner 1,117,925
US:US92942V2088 / VYANT BIO INC Director 4,781,204
US:HH / Hooper Holmes, Inc. 10% Owner 1,750,930
US:GNOW / American Caresource Holdings, Inc. Director, 10% Owner 6,278,672
US:KURA / Kura Oncology, Inc. President, Director, 10% Owner 0
US:CONM / Conmed Healthcare Management, Inc. Director, 10% Owner 0
US:PIP / PharmAthene, Inc. Director 10,000
如何解读这些图表

以下图表显示了在John Pappajohn进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

ALT / Altimmune, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALT / Altimmune, Inc. Insider Trades
ALT / Altimmune, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALT / Altimmune, Inc. Insider Trades
KURA / Kura Oncology, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

KURA / Kura Oncology, Inc. Insider Trades
KURA / Kura Oncology, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

KURA / Kura Oncology, Inc. Insider Trades
MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock)内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2019-05-23 MYND PAPPAJOHN JOHN 200,000 1.2540 28,571 8.7780 250,800 731
2019-03-14 MYND PAPPAJOHN JOHN 100,000 1.6760 14,286 11.7320 167,600
2018-08-28 MYND PAPPAJOHN JOHN 50,000 1.6200 7,143 11.3400 81,000
2018-08-28 MYND PAPPAJOHN JOHN 50,000 1.6300 7,143 11.4100 81,500
2018-01-05 MYND PAPPAJOHN JOHN 10,000 3.4378 1,429 24.0646 34,378
2017-08-09 MYND PAPPAJOHN JOHN 5,000 3.3367 714 23.3569 16,684
2017-08-02 MYND PAPPAJOHN JOHN 5,000 3.6484 714 25.5388 18,242
2017-07-25 MYND PAPPAJOHN JOHN 5,000 3.9992 714 27.9944 19,996
2017-07-21 MYND PAPPAJOHN JOHN 5,000 4.3000 714 30.1000 21,500
2017-07-21 MYND PAPPAJOHN JOHN 5,000 4.1986 714 29.3902 20,993
2017-07-18 MYND PAPPAJOHN JOHN 5,000 4.5389 714 31.7723 22,694
2017-07-17 MYND PAPPAJOHN JOHN 5,000 4.4000 714 30.8000 22,000
2017-04-03 MYAN PAPPAJOHN JOHN 9,878 6.4632 9,878 6.4632 63,843
2016-10-20 MYAN PAPPAJOHN JOHN 200 8.5000 200 8.5000 1,700
2016-10-17 MYAN PAPPAJOHN JOHN 1,000 8.0000 1,000 8.0000 8,000
2016-10-12 MYAN PAPPAJOHN JOHN 16 7.5000 16 7.5000 120
2016-10-10 MYAN PAPPAJOHN JOHN 1,839 6.4527 1,839 6.4527 11,867

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock)内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ALT / Altimmune, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
内幕交易历史

该表格显示了由 John Pappajohn 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2019-07-18 2019-07-16 4 NONE Telemynd, Inc.
Series A Preferred Stock
J - Other 1,000,000 1,000,000
2019-07-18 2019-07-16 4 NONE Telemynd, Inc.
Common Stock
J - Other 1,132,925 1,132,925
2019-05-23 2019-05-23 4 MYND MYnd Analytics, Inc.
COMMON STOCK
P - Purchase 200,000 1,117,925 21.79 1.25 250,800 1,401,878
2019-03-14 2019-03-14 4 MYND MYnd Analytics, Inc.
COMMON STOCK
P - Purchase 100,000 917,925 12.23 1.68 167,600 1,538,442
2019-02-01 2019-01-31 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 1,000,000 4,781,204 26.45 0.23 230,000 1,099,677
2019-01-16 2019-01-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 1,000,000 3,781,204 35.96 0.22 225,000 850,771
2018-10-10 2018-10-08 4 MYND MYnd Analytics, Inc.
COMMON STOCK
A - Award 30,000 832,925 3.74 1.38 41,400 1,149,436
2018-09-25 2018-09-24 4 MYND MYnd Analytics, Inc.
Common Stock Purchase Warrant
A - Award 135,135 135,135
2018-09-25 2018-09-24 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 135,135 802,925 20.24 1.85 250,000 1,485,411
2018-08-28 2018-08-28 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 50,000 667,790 8.09 1.63 81,500 1,088,498
2018-08-28 2018-08-28 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 50,000 617,790 8.81 1.62 81,000 1,000,820
2018-08-28 2018-08-28 4/A MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 50,000 667,790 8.09 1.63 81,500 1,088,498
2018-08-28 2018-08-28 4/A MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 50,000 617,790 8.81 1.62 81,000 1,000,820
2018-05-30 2018-05-25 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 4,500 567,790 0.80 2.27 10,215 1,288,883
2018-04-02 2018-03-29 4 MYND MYnd Analytics, Inc.
Warrant
A - Award 500,000 500,000 62,500.00 31,250,000,000 31,250,000,000
2018-04-02 2018-03-29 4 MYND MYnd Analytics, Inc.
Warrant
A - Award 500,000 500,000 62,500.00 31,250,000,000 31,250,000,000
2018-04-02 2018-03-29 4 MYND MYnd Analytics, Inc.
Series A Preferred Stock
A - Award 500,000 500,000 937,500.00 468,750,000,000 468,750,000,000
2018-04-02 2018-03-29 4 MYND MYnd Analytics, Inc.
Series A Preferred Stock
A - Award 500,000 500,000 937,500.00 468,750,000,000 468,750,000,000
2018-01-08 2018-01-05 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 10,000 563,290 1.81 3.44 34,378 1,936,478
2017-12-11 2017-12-08 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 150,000 2,781,204 5.70 1.86 279,000 5,173,039
2017-10-02 2017-09-28 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 5,000 5,000
2017-10-02 2017-09-28 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 2,631,204 0.10
2017-09-21 2017-09-19 4 MYND MYnd Analytics, Inc.
Director Stock Option (right to buy)
A - Award 12,000 12,000
2017-09-21 2017-09-19 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 12,000 553,290 2.22
2017-08-18 2017-08-17 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 20,000 2,628,704 0.77 3.28 65,560 8,616,892
2017-08-18 2017-08-17 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 66,185 2,608,704 2.60 3.24 214,108 8,439,157
2017-08-18 2017-08-18 4/A CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 20,000 2,628,704 0.77 3.28 65,560 8,616,892
2017-08-18 2017-08-17 4/A CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 66,185 2,608,704 2.60 3.24 214,108 8,439,157
2017-08-10 2017-08-09 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 541,290 0.93 3.34 16,684 1,806,122
2017-08-03 2017-08-02 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 536,290 0.94 3.65 18,242 1,956,600
2017-07-26 2017-07-25 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 531,290 0.95 4.00 19,996 2,124,735
2017-07-25 2017-07-21 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 526,290 0.96 4.20 20,993 2,209,681
2017-07-25 2017-07-21 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 521,290 0.97 4.30 21,500 2,241,547
2017-07-19 2017-07-18 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 516,290 0.98 4.54 22,694 2,343,389
2017-07-19 2017-07-17 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 5,000 511,290 0.99 4.40 22,000 2,249,676
2017-06-12 2017-06-12 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 100,000 2,542,519 4.09 3.75 374,870 9,531,141
2017-06-08 2017-06-07 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2017-06-08 2017-06-07 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 2,442,519 0.10
2017-05-17 2017-05-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 19,310 2,440,019 0.80 3.80 73,318 9,264,508
2017-04-21 2017-04-06 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 59 1,750,930 0.00 0.85 50 1,488,290
2017-04-21 2017-04-05 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 474 1,750,871 0.03 0.85 403 1,488,240
2017-04-21 2017-04-04 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 12,125 1,750,397 0.70 0.85 10,306 1,487,837
2017-04-21 2017-03-24 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 3,186 1,738,272 0.18 0.75 2,388 1,302,661
2017-04-21 2017-03-23 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 4,300 1,735,086 0.25 0.75 3,225 1,301,314
2017-04-21 2017-03-22 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 20,077 1,730,786 1.17 0.75 15,050 1,297,397
2017-04-21 2017-03-17 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 1,400 1,710,709 0.08 0.75 1,047 1,278,926
2017-04-21 2017-03-16 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 700 1,709,309 0.04 0.75 525 1,281,982
2017-04-21 2017-03-15 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 336 1,708,609 0.02 0.75 252 1,281,457
2017-04-21 2017-03-14 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 15,852 1,708,273 0.94 0.74 11,795 1,271,126
2017-04-21 2017-03-09 4 HH HOOPER HOLMES INC
Common Stock
P - Purchase 100,000 1,692,421 6.28 0.73 72,660 1,229,713
2017-04-21 3 HH HOOPER HOLMES INC
Common Stock
3,184,842
2017-04-21 3 HH HOOPER HOLMES INC
Common Stock
3,184,842
2017-04-06 2017-04-03 4 MYAN MYnd Analytics, Inc.
Common Stock
P - Purchase 9,878 506,290 1.99 6.46 63,843 3,272,254
2017-03-22 2017-03-21 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 40,000 496,412 8.76 6.25 250,000 3,102,575
2017-02-14 2017-02-10 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 32,000 456,412 7.54 6.25 200,000 2,852,575
2016-12-30 2016-12-29 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 16,000 424,412 3.92 6.25 100,000 2,652,575
2016-12-02 2016-11-30 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 32,000 408,412 8.50 6.25 200,000 2,552,575
2016-11-29 2016-11-28 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 100,000 2,420,709 4.31 1.45 145,280 3,516,806
2016-11-16 2016-11-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 31,100 2,320,709 1.36 1.48 46,050 3,436,274
2016-11-02 2016-11-01 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 20,000 376,412 5.61
2016-10-24 2016-10-20 4 MYAN MYnd Analytics, Inc.
Common Stock
P - Purchase 200 356,412 0.06 8.50 1,700 3,029,502
2016-10-19 2016-10-17 4 MYAN MYnd Analytics, Inc.
Common Stock
P - Purchase 1,000 356,212 0.28 8.00 8,000 2,849,696
2016-10-14 2016-10-12 4 MYAN MYnd Analytics, Inc.
Common Stock
P - Purchase 16 355,212 0.00 7.50 120 2,664,090
2016-10-13 2016-10-11 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2016-10-13 2016-10-11 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 2,289,609 0.11
2016-10-12 2016-10-10 4 MYAN MYnd Analytics, Inc.
Common Stock
P - Purchase 1,839 355,196 0.52 6.45 11,867 2,291,973
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
D - Sale to Issuer 0
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
M - Exercise
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
Common Stock
M - Exercise 290,498 353,357 462.14 5.00 1,452,490 1,766,785
2016-09-20 2016-09-16 4 CNSO MYnd Analytics, Inc.
Common Stock
G - Gift -6,538,258 12,571,699 -34.21
2016-08-17 2016-08-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 45,000 2,287,109 2.01 2.29 103,203 5,245,256
2016-08-16 2016-08-15 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 79,722 2,242,109 3.69 2.20 175,636 4,939,590
2016-08-16 2016-08-12 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 67,778 2,162,387 3.24 2.10 142,652 4,551,176
2016-08-11 2016-08-09 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 28,000,000
2016-08-11 2016-08-09 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 2,000,000 28,000,000 7.69
2016-07-25 2016-07-21 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 26,000,000
2016-07-25 2016-07-21 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 5,000,000 26,000,000 23.81
2016-07-19 2016-05-25 4/A CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 317,820 2,094,609 17.89
2016-07-05 2016-06-30 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 46,112 6,278,672 0.74 0.20 9,222 1,255,734
2016-06-30 2016-06-29 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 13,800 6,232,560 0.22 0.20 2,760 1,246,512
2016-06-29 2016-06-28 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 26,453 6,245,213 0.43 0.20 5,291 1,249,043
2016-06-29 2016-06-27 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 5,000 6,218,760 0.08 0.20 1,000 1,243,752
2016-06-27 2016-06-24 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 26,500 6,213,760 0.43 0.20 5,300 1,242,752
2016-06-27 2016-06-23 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 27,000 6,187,260 0.44 0.20 5,400 1,237,452
2016-06-23 2016-06-22 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 11,909 6,160,260 0.19 0.19 2,256 1,166,753
2016-06-23 2016-06-21 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 20,600 6,148,351 0.34 0.18 3,708 1,106,703
2016-06-21 2016-06-20 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 5,383 6,127,751 0.09 0.20 1,077 1,225,550
2016-06-14 2016-06-13 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 29,148 6,122,368 0.48 0.20 5,830 1,224,474
2016-06-13 2016-06-09 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 53,000 6,093,220 0.88 0.20 10,600 1,218,644
2016-06-08 2016-06-07 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 4,500 6,040,220 0.07 0.20 900 1,208,044
2016-06-01 2016-05-31 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 32,363 6,035,720 0.54 0.20 6,473 1,207,144
2016-05-31 2016-05-27 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 15,000 6,003,357 0.25 0.20 3,000 1,200,671
2016-05-27 2016-05-25 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 72,211 5,988,357 1.22 0.20 14,442 1,197,671
2016-05-26 2016-05-25 4 CGIX CANCER GENETICS, INC
Warrant (right to buy)
P - Purchase 158,910 158,910
2016-05-26 2016-05-25 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 317,820 2,099,609 17.84
2016-05-26 2015-08-27 4/A CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 1,524,289 0.16 10.25 25,624 15,623,353
2016-05-26 2015-08-26 4/A CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 1,521,789 0.16 8.97 22,436 13,657,143
2016-05-25 2016-05-24 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 25,008 5,916,146 0.42 0.20 5,002 1,183,229
2016-05-24 2016-05-23 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 71,878 5,891,138 1.24 0.20 14,376 1,178,228
2016-05-23 2016-05-20 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 59,000 5,819,260 1.02 0.20 11,800 1,163,852
2016-05-20 2016-05-19 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
P - Purchase 100,000 5,760,260 1.77 0.17 17,420 1,003,437
2016-04-13 2016-04-11 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 21,000,000
2016-04-13 2016-04-11 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 5,000,000 21,000,000 31.25
2016-04-07 2016-04-05 4 CNSO MYnd Analytics, Inc.
Common Stock
A - Award 250,000 19,109,957 1.33
2016-04-04 2016-03-31 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 16,000,000
2016-04-04 2016-03-31 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 5,000,000 16,000,000 45.45
2016-04-04 2016-03-31 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
A - Award 493,500 5,660,260 9.55 0.41 199,966 2,293,537
2016-03-17 2016-03-17 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 50,000 1,771,789 2.90 2.64 132,060 4,679,649
2016-03-16 2016-03-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 10,579 1,721,789 0.62 2.62 27,734 4,513,842
2016-03-16 2016-03-15 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 89,421 1,711,210 5.51 2.52 225,144 4,308,485
2015-12-28 2015-12-23 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 11,000,000
2015-12-28 2015-12-23 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 6,000,000 11,000,000 120.00
2015-12-28 2015-12-23 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 5,000,000 5,000,000
2015-12-11 2015-12-09 4 GNOW American CareSource Holdings, Inc.
Warrant to Purchase Common Stock
A - Award 2,857,142 2,857,142
2015-12-11 2015-12-09 4 GNOW American CareSource Holdings, Inc.
Common Stock, par value $0.01 per share
A - Award 2,857,142 5,166,760 123.71
2015-11-16 2015-11-12 4 CGIX CANCER GENETICS, INC
Warrant (right to buy)
P - Purchase 100,000 100,000
2015-11-16 2015-11-12 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 100,000 1,621,789 6.57
2015-10-16 2015-10-14 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2015-10-16 2015-10-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 1,521,789 0.16
2015-09-16 2015-09-15 4 CNSO CNS RESPONSE, INC.
5% Secured Convertible Note due March 2016
A - Award
2015-09-16 2015-09-14 4 CNSO CNS RESPONSE, INC.
5% Secured Convertible Note due March 2016
A - Award
2015-09-04 2015-09-02 4 ANCI American CareSource Holdings, Inc.
Warrant to Purchase Common Stock, par value $0.01 per share
A - Award 150,000 150,000
2015-09-01 2015-08-28 4 ANCI American CareSource Holdings, Inc.
Common Stock
A - Award 10,000 2,289,398 0.44
2015-08-27 2015-08-27 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 1,519,289 0.16 10.25 25,624 15,572,105
2015-08-27 2015-08-26 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 1,516,789 0.17 8.97 22,436 13,612,271
2015-08-24 2015-08-20 4 CNSO CNS RESPONSE, INC.
Option to Purchase
A - Award 250,000 250,000
2015-05-18 2015-05-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 5,000 1,519,289 0.33 10.74 53,700 16,317,164
2015-04-27 2015-04-24 4 ANCI American CareSource Holdings, Inc.
Stock option (right to buy)
M - Exercise -18,744 0 -100.00
2015-04-27 2015-04-24 4 ANCI American CareSource Holdings, Inc.
Common Stock
M - Exercise 18,744 2,279,398 0.83 0.93 17,488 2,126,678
2015-03-18 2015-03-17 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 15,000 1,514,289 1.00 7.15 107,236 10,825,803
2015-03-18 2015-03-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 35,000 1,499,289 2.39 7.45 260,586 11,162,656
2015-03-10 2015-03-06 4 NONE ZETA ACQUISITION CORP III
Common Stock, par value $0.0001 per share
D - Sale to Issuer -2,000,000 0 -100.00
2014-12-17 2014-12-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 5,589 1,464,289 0.38 6.20 34,652 9,078,592
2014-12-16 2014-12-15 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 3,634 1,458,700 0.25 6.14 22,313 8,956,418
2014-12-12 2014-12-11 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 27,087 1,455,066 1.90 6.03 163,335 8,774,048
2014-12-11 2014-12-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 5,773 1,427,979 0.41 5.96 34,407 8,510,755
2014-12-10 2014-12-09 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 15,986 1,422,206 1.14 5.70 91,120 8,106,574
2014-12-10 2014-12-08 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 23,700 1,406,220 1.71 5.11 121,107 7,185,784
2014-12-08 2014-12-04 4 ANCI American Caresource Holdings, Inc.
Warrant to Purchase Common Stock
A - Award 480,000 480,000
2014-08-01 2014-07-30 4 ANCI American Caresource Holdings, Inc.
Warrant to Purchase Common Stock
A - Award 440,000 440,000
2014-06-12 2014-06-10 4 CGIX CANCER GENETICS, INC
Warrant (right to buy)
M - Exercise 44,288 0 -100.00
2014-06-12 2014-06-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
M - Exercise 44,288 1,382,520 3.31 4.00 177,152 5,530,080
2014-06-05 2014-06-03 4 ANCI American Caresource Holdings, Inc.
Common Stock, $0.01 par value per share
A - Award 10,000 2,302,665 0.44
2014-05-27 2014-05-22 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 100,000 100,000
2014-05-27 2014-05-22 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 25,000 1,338,232 1.90
2014-05-21 2014-05-21 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 5,000 1,313,232 0.38 10.66 53,300 13,999,053
2014-05-21 2014-05-20 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 30,000 1,308,232 2.35 10.35 310,500 13,540,201
2014-05-21 2014-05-19 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 15,000 1,278,232 1.19 10.10 151,500 12,910,143
2014-05-07 2014-05-05 4 ANCI American Caresource Holdings, Inc.
Common Stock, $0.01 par value per share
P - Purchase 575,000 2,292,665 33.48 2.00 1,150,000 4,585,330
2013-10-15 2013-10-10 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2013-09-20 2013-09-19 4 ANCI American Caresource Holdings, Inc.
Common Stock, $0.01 par value per share
P - Purchase 3,400 1,717,665 0.20 1.82 6,188 3,126,150
2013-09-20 2013-09-18 4 ANCI American Caresource Holdings, Inc.
Common Stock, $0.01 par value per share
P - Purchase 1,300 1,714,265 0.08 1.70 2,210 2,914,250
2013-09-20 2013-09-18 4 ANCI American Caresource Holdings, Inc.
Common Stock, $0.01 par value per share
P - Purchase 100 1,712,965 0.01 1.73 173 2,963,429
2013-08-30 2013-08-30 4 CNSO CNS RESPONSE, INC.
Common Stock
A - Award 400,000 18,859,957 2.17 0.25 100,000 4,714,989
2013-08-14 2013-08-12 4 CNSO CNS RESPONSE, INC.
Convertible Note
M - Exercise 0
2013-08-14 2013-08-12 4 CNSO CNS RESPONSE, INC.
Common Stock
M - Exercise 7,318,228 18,459,957 65.68 0.25 1,829,557 4,614,989
2013-06-06 2013-03-21 4 CNSO CNS RESPONSE, INC.
Convertible Note
M - Exercise 0
2013-06-06 2013-03-21 4 CNSO CNS RESPONSE, INC.
Common Stock
M - Exercise 6,538,258 11,141,729 142.03 0.05 308,606 525,890
2013-06-06 2013-01-25 4 CNSO CNS RESPONSE, INC.
Convertible Note
M - Exercise
2013-06-06 2013-01-25 4 CNSO CNS RESPONSE, INC.
Common Stock
M - Exercise 4,300,551 4,603,471 1,419.70 0.05 202,986 217,284
2013-06-04 2013-05-30 4 ANCI American Caresource Holdings, Inc.
Common Stock
A - Award 10,000 1,722,865 0.58
2013-05-28 2013-05-23 4 CNSO CNS RESPONSE, INC.
Option to Purchase
A - Award 250,000 250,000
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Convertible Note
C - Conversion 0
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Series A-1 Convertible Preferred Stock
C - Conversion -377,789 0 -100.00
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Convertible Note
C - Conversion 0
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Convertible Note
C - Conversion 0
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Convertible Note
C - Conversion 0
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
C - Conversion 80,686 1,263,232 6.82
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 200,000 1,182,546 20.36
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 200,000 1,182,546 20.36
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 100,000 782,546 14.65
2013-04-12 2013-04-10 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 175,000 682,546 34.48
2013-04-04 3 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
307,546
2013-04-04 3 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
200,000
2012-12-13 2012-11-28 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
D - Sale to Issuer 83,334 0 -100.00
2012-12-13 2012-11-28 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
D - Sale to Issuer 83,334 0 -100.00
2012-12-13 2012-11-28 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
D - Sale to Issuer 83,334 0 -100.00
2012-12-13 2012-11-28 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
D - Sale to Issuer 126,949 0 -100.00
2012-12-13 2012-11-28 4 CNSO CNS RESPONSE, INC.
Convertible Promissory Notes
A - Award
2012-08-30 2012-08-29 4 CONM Conmed Healthcare Management, Inc.
Employee Stock Option (right to buy)
D - Sale to Issuer -40,000 0 -100.00 1.40 -56,000
2012-08-30 2012-08-28 4 CONM Conmed Healthcare Management, Inc.
Common Stock
D - Sale to Issuer -5,496 0 -100.00 3.95 -21,709
2012-08-30 2012-08-28 4 CONM Conmed Healthcare Management, Inc.
Common Stock
D - Sale to Issuer -5,000 0 -100.00 3.95 -19,750
2012-08-30 2012-08-28 4 CONM Conmed Healthcare Management, Inc.
Common Stock
D - Sale to Issuer -1,539,012 0 -100.00 3.95 -6,079,097
2012-07-18 2012-07-16 4 CONM Conmed Healthcare Management, Inc.
Common Stock
G - Gift -1,000,000 1,539,012 -39.39
2012-05-29 2012-05-24 4 CONM Conmed Healthcare Management, Inc.
Common Stock
M - Exercise 10,000 2,539,012 0.40
2012-02-22 2012-02-21 4 CONM Conmed Healthcare Management, Inc.
Restricted Stock Units
A - Award 10,000 10,000
2012-01-05 2011-12-27 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
A - Award 2,500,000 7,500,000 50.00
2012-01-05 2011-12-27 4 CNSO CNS RESPONSE, INC.
Subordinated Convertible Note
A - Award 250,000 750,000 50.00
2012-01-05 2011-11-11 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
A - Award 2,500,000 5,000,000 100.00
2012-01-05 2011-11-11 4 CNSO CNS RESPONSE, INC.
Subordinated Convertible Note
A - Award 250,000 500,000 100.00
2012-01-05 2011-11-11 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
A - Award 1,250,000 2,500,000 100.00
2012-01-05 2011-10-18 4 CNSO CNS RESPONSE, INC.
Common Stock Warrant
A - Award 1,250,000 1,250,000
2012-01-05 2011-10-18 4 CNSO CNS RESPONSE, INC.
Subordinated Convertible Note
A - Award 250,000 250,000
2009-03-11 2009-03-09 4 PIP PHARMATHENE, INC
Stock option (right to buy)
A - Award 10,000 10,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)